GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, email@example.com
Index / US Biomax / Renal disease spectrum tissue array, with stage and TNM info, 104 cases_208 cores; ihc Anti-Actin confirmed / Product Detail : KD2084 Renal disease spectrum tissue array, with stage and TNM info, 104 cases_208 cores; ihc Anti-Actin confirmed
#KD2084 Renal disease spectrum tissue array, with stage and TNM info, 104 cases_208 cores; ihc Anti-Actin confirmed
Product name : Renal disease spectrum tissue array, with stage and TNM info, 104 cases_208 cores; ihc Anti-Actin confirmed
Catalog number : KD2084
Supplier name : US Biomax
Data sheet: Ask more or other datasheet now !
About this Product :Renal disease spectrum tissue array, with stage and TNM info, 104 cases_208 cores; ihc Anti-Actin confirmed antibody storage GENTAUR recommends for long therm storage to freeze at -24 C. For short time storage up to 30 days we suggest fridge storage at 1 to 10 C. Prevent multiple freeze taw cycles of Renal disease spectrum tissue array, with stage and TNM info, 104 cases_208 cores; ihc Anti-Actin confirmed.
Renal disease spectrum tissue array, with stage and TNM info, 104 cases_208 cores; ihc Anti-Actin confirmed storing antibdies for longer storage periods of the Renal disease spectrum tissue array, with stage and TNM info, 104 cases_208 cores; ihc Anti-Actin confirmed we recommend - 21C or lower and for short periods lees than 1 month we suggest +5C fridge temperatures.
More Details about
|Microarray Panel:||Kidney disease spectrum tissue microarray, containing 30 cases of kidney clear cell carcinoma, 2 collecting duct carcinoma, 5 squamous cell carcinoma, 10 wilms' tumor, 10 papillary renal cell carcinoma, 18 transitional cell carcinoma, 2 undifferentiated carcinoma, 5 metastatic carcinoma, 2 hyperplasia, 5 inflammation, 10 adjacent normal kidney tissue and 5 normal tissue, duplicate cores per case|
|Layout:||16 cols × 13 rows|
|Core Diameter:||1 mm|
|Quality Control:||Anti-Actin confirmed|
|Applications:||Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.|
|Notes:||Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.|
*Tissue Microarray Slide Types:
- Unstained: unstained paraffin tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Contact us about this product :
Our team will respond you as soon as possible !
We have also other products like : Renal disease spectrum tissue array, with stage and TNM info, 104 cases_208 cores; ihc Anti-Actin confirmed
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
firstname.lastname@example.org | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP1019: FAS pathway and Stress induction of HSP regulation
WP1062: Regulation of Actin Cytoskeleton
WP1138: FAS pathway and Stress induction of HSP regulation
WP1178: Regulation of Actin Cytoskeleton
WP1380: Regulation of Actin Cytoskeleton
WP1963: The effect of Glucocorticoids on target gene expression
WP2059: Alzheimers Disease
WP2075: Alzheimers Disease
WP2199: Seed Development
WP2272: Pathogenic Escherichia coli infection
WP2292: Chemokine signaling pathway
WP2371: Parkinsons Disease Pathway
WP314: FAS pathway and Stress induction of HSP regulation
WP351: Regulation of Actin Cytoskeleton
WP51: Regulation of Actin Cytoskeleton
WP511: FAS pathway and Stress induction of HSP regulation
WP523: Regulation of Actin Cytoskeleton
WP571: FAS pathway and Stress induction of HSP regulation
WP788: FAS pathway and Stress induction of HSP regulation
WP824: Regulation of Actin Cytoskeleton
WP89: FAS pathway and Stress induction of HSP regulation
WP902: FAS pathway and Stress induction of HSP regulation
WP944: Regulation of Actin Cytoskeleton
Related Genes :
[LMNA LMN1] Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)]
[STK11 LKB1 PJS] Serine/threonine-protein kinase STK11 (EC 220.127.116.11) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19)
[HSP90AA1 HSP90A HSPC1 HSPCA] Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38)
[AVPR2 ADHR DIR DIR3 V2R] Vasopressin V2 receptor (V2R) (AVPR V2) (Antidiuretic hormone receptor) (Renal-type arginine vasopressin receptor)
[ROCK1] Rho-associated protein kinase 1 (EC 18.104.22.168) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK)
[NCOA1 BHLHE74 SRC1] Nuclear receptor coactivator 1 (NCoA-1) (EC 22.214.171.124) (Class E basic helix-loop-helix protein 74) (bHLHe74) (Protein Hin-2) (RIP160) (Renal carcinoma antigen NY-REN-52) (Steroid receptor coactivator 1) (SRC-1)
[RBPJ IGKJRB IGKJRB1 RBPJK RBPSUH] Recombining binding protein suppressor of hairless (CBF-1) (J kappa-recombination signal-binding protein) (RBP-J kappa) (RBP-J) (RBP-JK) (Renal carcinoma antigen NY-REN-30)
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[STX4 STX4A] Syntaxin-4 (Renal carcinoma antigen NY-REN-31)
[TP53BP2 ASPP2 BBP] Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein) (Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2) (53BP2) (p53-binding protein 2) (p53BP2)
[UBE3A E6AP EPVE6AP HPVE6A] Ubiquitin-protein ligase E3A (EC 6.3.2.-) (E6AP ubiquitin-protein ligase) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54)
[DPEP1 MDP RDP] Dipeptidase 1 (EC 126.96.36.199) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP)
[AQP2] Aquaporin-2 (AQP-2) (ADH water channel) (Aquaporin-CD) (AQP-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct)
[CRYAB CRYA2 HSPB5] Alpha-crystallin B chain (Alpha(B)-crystallin) (Heat shock protein beta-5) (HspB5) (Renal carcinoma antigen NY-REN-27) (Rosenthal fiber component)
[NPHS1 NPHN] Nephrin (Renal glomerulus-specific cell adhesion receptor)
[BCR BCR1 D22S11] Breakpoint cluster region protein (EC 188.8.131.52) (Renal carcinoma antigen NY-REN-26)
[CTNNA1] Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13)
[RNF139 TRC8] E3 ubiquitin-protein ligase RNF139 (EC 6.3.2.-) (RING finger protein 139) (Translocation in renal carcinoma on chromosome 8 protein)
[NOX4 RENOX] NADPH oxidase 4 (EC 1.6.3.-) (Kidney oxidase-1) (KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase)
[SLC22A12 OATL4 URAT1 UNQ6453/PRO34004] Solute carrier family 22 member 12 (Organic anion transporter 4-like protein) (Renal-specific transporter) (RST) (Urate anion exchanger 1)
[USH1C AIE75] Harmonin (Antigen NY-CO-38/NY-CO-37) (Autoimmune enteropathy-related antigen AIE-75) (Protein PDZ-73) (Renal carcinoma antigen NY-REN-3) (Usher syndrome type-1C protein)
[EPHB2 DRT EPHT3 EPTH3 ERK HEK5 TYRO5] Ephrin type-B receptor 2 (EC 184.108.40.206) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3)
[Ctnnb1 Catnb] Catenin beta-1 (Beta-catenin)
[SLC22A6 OAT1 PAHT] Solute carrier family 22 member 6 (Organic anion transporter 1) (hOAT1) (PAH transporter) (hPAHT) (Renal organic anion transporter 1) (hROAT1)
[RET CDHF12 CDHR16 PTC RET51] Proto-oncogene tyrosine-protein kinase receptor Ret (EC 220.127.116.11) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment]
[Aqp2] Aquaporin-2 (AQP-2) (ADH water channel) (Aquaporin-CD) (AQP-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct)
[NEDD9 CASL CASS2] Enhancer of filamentation 1 (hEF1) (CRK-associated substrate-related protein) (CAS-L) (CasL) (Cas scaffolding protein family member 2) (Neural precursor cell expressed developmentally down-regulated protein 9) (NEDD-9) (Renal carcinoma antigen NY-REN-12) (p105) [Cleaved into: Enhancer of filamentation 1 p55]
[CA9 G250 MN] Carbonic anhydrase 9 (EC 18.104.22.168) (Carbonate dehydratase IX) (Carbonic anhydrase IX) (CA-IX) (CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250) (RCC-associated antigen G250) (pMW1)
[LIMS1 PINCH PINCH1] LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) (Renal carcinoma antigen NY-REN-48)
[LDHA PIG19] L-lactate dehydrogenase A chain (LDH-A) (EC 22.214.171.124) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59)
 The cardiovascular markers copeptin and high-sensitive C-reactive protein decrease following specific therapy for primary aldosteronism.
 Extreme hydronephrosis due to uretropelvic junction obstruction in infant (case report).
 Polydactyly and obesity - the clinical manifestation of ciliopathy: a boy with Bardet-Biedl syndrome.
 Impact of sex disparities on the clinical manifestations in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
 Association of gender and length of stay among Puerto Ricans hospitalized with decompensated heart failure.
 Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.
 Zero-order metoprolol pharmacokinetics after therapeutic doses: severe toxicity and cardiogenic shock.
 Chronic Kidney Disease, Fluid Overload and Diuretics: A Complicated Triangle.
 Genovariation Study of Hantavirus in Main Endemic Areas of Hemorrhagic Fever with Renal Syndrome in Hebei Province, China.
 Pregnancy Outcomes in Chinese Patients with Systemic Lupus Erythematosus (SLE): A Retrospective Study of 109 Pregnancies.
Enter catalog number :